Duke of Gloucester opens Vindon headquarters in Rochdale, UK
Facilities to support growth plans
Vindon Scientific operates in several markets, including the healthcare, pharmaceutical, life sciences, food sectors and heritage sectors. It is a leading supplier of environmental control products and services for the management of temperature, humidity and light, where controlled environment storage is needed.
The Duke of Gloucester formally opened the new state-of-the-art premises and met Vindon’s directors who gave him a tour of the 29,000ft2 facilities, which are now fully operational and geared up to support the company's ambitious growth plans.
His Royal Highness was shown the specialist products and services that Vindon provides, including stability storage, ultra-low temperature facilities and cryogenic sample storage for stem cells.
‘It was good to see that companies such as Vindon were investing in future technologies,’ he said.
Patrick Jackson, business development director at Vindon, added: ‘We were delighted to welcome the Duke of Gloucester to our new home here at Kingsway. To be chosen to represent this area of Rochdale is a great honour. We’re pleased to see continued investment in the Business Park, which will encourage more new ventures to join us.’
The Lord Lieutenant of Greater Manchester, the Mayor of Rochdale, Zulfiqar Ali, and leader of Rochdale Council, Irene Davidson, accompanied HRH Duke of Gloucester on his visit.
You may also like
Manufacturing
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market